News search

    E.g., 28/11/2024
    E.g., 28/11/2024
    About the CNIC
    12 Jun 2019
    Dr. Miguel Torres elected a member of the European Molecular Biology Organization – EMBO

    EMBO promotes excellence in scientific research, and one of its major goals is to support talented researchers at all stages of their careers
    Rui Benedito, Macarena Fernández Chacón, Verónica Casquero García, Federica Lunella y Wen Luo.
    Research
    22 May 2019
    Nature Communications: A new genetic tool to modify and understand gene function

    CNIC scientists have developed a new genetic tool that significantly facilitates the study of gene function in physiological conditions and disease.
    Luis Leiva-Vega, Juan Antonio Bernal, Marta Roche-Molina, Ayelén M. Santamans, Valle Montalvo-Romeral, Aránzazu Pintor-Chocano, Rafael Romero-Becerra, Ainoa Caballero, Alfonso Mora, Guadalupe Sabio, Antonia Tomás-Loba, Marta León, Elena Rodríguez, Juan Antonio López, Jesús Vázquez.
    Research
    11 Apr 2019
    Nature: The protein p38gamma identified as a new therapeutic target in liver cancer

    CNIC scientists have shown for the first time that a protein related to cell stress also regulates cell division
    Pilar Gonzalo, Rosa Nevado, Ricardo Villa-Bellosta, Magda R. Hamczyk, María J. Andrés-Manzano, and Vicente Andrés.
    Research
    12 Mar 2019
    EMBO Molecular Medicine: CNIC scientists discover a new therapeutic target for blocking early atherosclerosis in progeria

    This new results, published in EMBO Molecular Medicine, identify a possible therapeutic target for this genetic disease
    About the CNIC
    18 Jan 2019
    The Pro CNIC Foundation extends its commitment with the CNIC until 2028
    • ·         The Pro CNIC Foundation prolongs its commitment until 2028, with the excellent cardiovascular research carried out at the CNIC under the management of Dr. Valentín Fuster
    • ·         The innovative public-private financing formula has allowed the CNIC to reach a very high level of excellence, making it worthy of the Severo Ochoa accreditation and other international recognitions 
    • The Pro CNIC joins together 12 of the most important companies in Spain: Acciona, Santander Bank, BBVA, Endesa, Mapfre Foundation, Mutua Madrileña Foundation, Ramón Areces Foundation, Repsol Foundation, Inditex, "la Caixa", Prisa and Telefónica.
    Research
    16 Jan 2019
    JACC: The duration and quality of sleep is of vital importance in cardiovascular health

    Poor quality sleep increases the risk of atherosclerosis according to the PESA CNIC- Santander Study published in the Journal of the American College of Cardiology (JACC)
    About the CNIC
    30 Nov 2018
    A Project by Borja Ibáñez from the CNIC and the FJD funded by the European Union with an ‘ERC Consolidator’
    Foto
    Research
    19 Nov 2018
    The CNIC Conference addresses the emerging concepts of cardiovascular biology

    The scientific event, which took place in Madrid, brought together more than 100 researchers from different fields of cardiovascular biology

    Research
    16 Nov 2018
    Nature Communications: Blocking hypertension with antihypertensive drugs prevents the development of a lethal disease

    The study results, published in the journal Nature Communications, identify several proteins implicated in this disease
    From left to right: David Sancho, Carlos del Fresno, Paula Saz, and Sarai Martínez Cano.
    Research
    19 Oct 2018
    Science: A new mechanism in the control of inflammation

    CNIC researchers have discovered a new inflammatory control mechanism that paves the way to controlling injury generated during the immune response